These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 23298622)
1. In situ forming nimodipine depot system based on microparticles for the treatment of posthemorrhagic cerebral vasospasm. Bege N; Renette T; Endres T; Beck-Broichsitter M; Hänggi D; Kissel T Eur J Pharm Biopharm; 2013 May; 84(1):99-105. PubMed ID: 23298622 [TBL] [Abstract][Full Text] [Related]
2. Local delivery of nimodipine by prolonged-release microparticles-feasibility, effectiveness and dose-finding in experimental subarachnoid hemorrhage. Hänggi D; Perrin J; Eicker S; Beseoglu K; Etminan N; Kamp MA; Heiroth HJ; Bege N; Macht S; Frauenknecht K; Sommer C; Kissel T; Steiger HJ PLoS One; 2012; 7(9):e42597. PubMed ID: 23049732 [TBL] [Abstract][Full Text] [Related]
3. Intracranial biodegradable silica-based nimodipine drug release implant for treating vasospasm in subarachnoid hemorrhage in an experimental healthy pig and dog model. Koskimäki J; Tarkia M; Ahtola-Sätilä T; Saloranta L; Simola O; Forsback AP; Laakso A; Frantzén J Biomed Res Int; 2015; 2015():715752. PubMed ID: 25685803 [TBL] [Abstract][Full Text] [Related]
4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884 [TBL] [Abstract][Full Text] [Related]
5. Letter by Rustemi Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])". Rustemi O Stroke; 2017 Apr; 48(4):e113. PubMed ID: 28283604 [No Abstract] [Full Text] [Related]
6. Response by Hänggi and Macdonald to Letter Regarding Article, "Randomized, Open-Label, Phase 1/2a Study to Determine the Maximum Tolerated Dose of Intraventricular Sustained Release Nimodipine for Subarachnoid Hemorrhage (NEWTON [Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage])". Hänggi D; Macdonald RL Stroke; 2017 Apr; 48(4):e114. PubMed ID: 28283608 [No Abstract] [Full Text] [Related]
7. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model. Hänggi D; Eicker S; Beseoglu K; Rapp M; Perrin J; Nawatny J; Turowski B; Sommer C; Steiger HJ Neurosurgery; 2009 Jun; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy. Hänggi D; Beseoglu K; Turowski B; Steiger HJ Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777 [TBL] [Abstract][Full Text] [Related]
9. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling. Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268 [TBL] [Abstract][Full Text] [Related]
13. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm. Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257 [TBL] [Abstract][Full Text] [Related]
14. Effect of the size of biodegradable microparticles on drug release: experiment and theory. Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035 [TBL] [Abstract][Full Text] [Related]
15. Intraarterial nimodipine for the treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a preliminary study. Dehdashti AR; Binaghi S; Uske A; Regli L Neurol India; 2011; 59(6):810-6. PubMed ID: 22234190 [TBL] [Abstract][Full Text] [Related]
16. Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage. Musahl C; Henkes H; Vajda Z; Coburger J; Hopf N Neurosurgery; 2011 Jun; 68(6):1541-7; discussion 1547. PubMed ID: 21311378 [TBL] [Abstract][Full Text] [Related]
17. Thermal behavior and stability of biodegradable spray-dried microparticles containing triamcinolone. da Silva AA; de Matos JR; Formariz TP; Rossanezi G; Scarpa MV; do Egito ES; de Oliveira AG Int J Pharm; 2009 Feb; 368(1-2):45-55. PubMed ID: 18992313 [TBL] [Abstract][Full Text] [Related]
18. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Kerz T; Boor S; Beyer C; Welschehold S; Schuessler A; Oertel J Br J Neurosurg; 2012 Aug; 26(4):517-24. PubMed ID: 22303863 [TBL] [Abstract][Full Text] [Related]
19. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity. Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound-Induced Release of Nimodipine from Drug-Loaded Block Copolymer Micelles: In Vivo Analysis. Döring K; Sperling S; Ninkovic M; Schroeder H; Fischer A; Stadelmann C; Streit F; Binder L; Mielke D; Rohde V; Malinova V Transl Stroke Res; 2022 Oct; 13(5):792-800. PubMed ID: 34988870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]